Viewing Study NCT01146535


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2025-12-30 @ 2:10 PM
Study NCT ID: NCT01146535
Status: COMPLETED
Last Update Posted: 2013-08-21
First Post: 2010-06-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment
Sponsor: Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module